CSF3 and neutropenia: The use of G-CSF is recommended by the American Society of Clinical Oncology and the National Comprehensive Cancer Network in patients receiving cytotoxic agent treatments to reduce the risk of neutropenia and its complications, enabling safe and effective chemotherapy dose intensity [31].